about
P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.Regenerative therapies for diabetic microangiopathyFetal cell identifiers: results of microscope slide-based immunocytochemical studies as a function of gestational age and abnormality.Down syndrome and cell-free fetal DNA in archived maternal serum.Enrichment of NRBC in maternal blood: a more feasible method for noninvasive prenatal diagnosis.PLAC1 mRNA in maternal blood correlates with Doppler waveform in uterine arteries in normal pregnancies at the second and third trimester.PP13 mRNA expression in trophoblasts from preeclamptic placentas.Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation.Vitamin B₆ supplementation in pregnant women with nausea and vomiting.Term delivery rate after hysteroscopic metroplasty in patients with recurrent spontaneous abortion and T-shaped, arcuate and septate uterus.Antioxidant supplementation in pregnant women with low antioxidant status.Rapid clearance of mRNA for PLAC1 gene in maternal blood after delivery.PLAC1 mRNA levels in maternal blood at induction of labor correlate negatively with induction-delivery interval.Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status.Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia.High doses of ursodeoxycholic acid up-regulate the expression of placental breast cancer resistance protein in patients affected by intrahepatic cholestasis of pregnancyRecent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.Nonabortal pregnancy complications of chorionic villous sampling.Steroid sulfatase expression in ovarian clear cell adenocarcinoma: immunohistochemical study.Circulating mRNA in Maternal Plasma at the Second Trimester of Pregnancy: A Possible Screening Tool for Cardiac Conotruncal and Left Ventricular Outflow Tract Abnormalities.Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis.Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia.Diagnosis of station and rotation of the fetal head in the second stage of labor with intrapartum translabial ultrasound.Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction--a pilot study.Heat shock response by EBV-immortalized B-lymphocytes from centenarians and control subjects: a model to study the relevance of stress response in longevity.Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism.Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening.Effects of epidural analgesia on labor length, instrumental delivery, and neonatal short-term outcome.Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia.P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.Akt, protein kinase C, and mitogen-activated protein kinase phosphorylation status in head and neck squamous cell carcinoma.Three-dimensional ultrasound in monitoring progression of labor: a reproducibility study.Amniocentesis and chorionic villus sampling in twin gestations: which is the best sampling technique?Non-syndromic orofacial clefts in Southern Italy: pattern analysis according to gender, history of maternal smoking, folic acid intake and familial diabetes.Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients.Offspring birth weight in second-generation 'small for gestational age' infants.pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.Delivery and immigration: the experience of an Italian hospital.Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood.
P50
Q24812605-11DCA93A-E875-45A4-A388-581C6042FFA8Q27027852-A8A08165-AA80-4DBA-8033-32755D065CB8Q30700649-ED1EAC04-6F94-4702-87E7-DF9495F407ABQ31119002-9C56C26D-90B4-4957-84B6-7A737C419D20Q33240876-4C5F5313-8B29-4679-8BF3-0E13A0D39887Q33263720-9D7FCDE2-D119-4F85-BAD2-4BF52F152423Q33393566-5345A6A2-80EC-4EF2-A901-DF3BC4A0D66EQ33528109-82C54CF3-273C-484A-908E-F72B504E370CQ34107929-F42A6325-C699-4B01-99F1-8C835BD07EA9Q34154513-5E11425C-51A9-4806-8D97-8CD422F2A968Q34260317-737283EB-311F-4041-804F-965D9B8A4F59Q34377985-2DF931E6-5635-4E85-BE9B-B678FF1696F4Q34550097-EF87A889-8158-400E-BE45-F1E274B6CF84Q34572076-D0238CC6-6910-43AD-9892-DF0F866F036EQ34635362-C4FDBDBA-2B4D-46A2-B4F7-B7A5AE4CFFD7Q34745175-B29ABFF6-E0BD-4A41-B2DE-E8ED83F34267Q37000825-37FBDB88-9ECB-4359-9CBA-C74AE139D276Q37836301-000FE441-2A5C-4066-9AC0-6AF8A3AFA944Q38459982-AA1A60CB-06AF-4696-8D81-2388061EAD9AQ38661074-8F1DE428-F119-4AA5-B87A-4FA59975F7CCQ39006810-0C8685BD-7145-4316-909D-15D26CD3D9DFQ39692869-BC631B54-8110-4185-8F38-7FE96A93180EQ39873078-ED536B83-42A4-4BCA-9944-37CF77611344Q40588231-1A7C20F4-3AE3-46C5-B582-070DD3F6C83BQ40599327-96705516-E2E5-4A58-8FED-D7DE8D749C9CQ40717942-2FF0A284-71C4-45F1-A0D8-A3ACC9B23565Q43197931-69B2467C-09E4-4A8B-B766-B4037272D4E6Q44067685-394190C0-B26D-498E-9087-6D1FE15D21A6Q44076540-D92AE80E-E681-4EF7-89AD-A28E32FC1DABQ45076246-F763AC31-B918-4C02-9E00-B8CEC1C0BB35Q45217544-FFD3F1E2-B497-445B-BC04-F38C11391F91Q46029626-8DD98231-934F-42B9-AEA5-3C3C9224033AQ46209791-3923DBC9-8297-4C67-A492-C90E200EB942Q46417039-D1A86906-9A5E-4A24-9598-FCF609A44C64Q46462668-E337CEE5-39F4-4DEF-A6F1-65C0228FC3C0Q46967281-9A9C4133-5A3B-4BEA-BDB3-337C3C0D77D4Q47430235-EF58A926-DB36-4D2C-9432-CEE1FF682347Q47433429-F1DDCCCF-80E5-4739-8CFA-7F514038B38AQ47595695-9368D323-A7CF-4ABC-A797-37F8BF645583Q47816303-A9549461-3E39-4750-A709-7D29BBAB8F5B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonio Farina
@ast
Antonio Farina
@en
Antonio Farina
@es
Antonio Farina
@nl
Antonio Farina
@sl
type
label
Antonio Farina
@ast
Antonio Farina
@en
Antonio Farina
@es
Antonio Farina
@nl
Antonio Farina
@sl
prefLabel
Antonio Farina
@ast
Antonio Farina
@en
Antonio Farina
@es
Antonio Farina
@nl
Antonio Farina
@sl
P106
P1153
55351970100
7202992430
P21
P31
P496
0000-0002-6862-1810